This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Childs, A. C. Articles by Leeuwenburgh, C. Search for Related Content PubMed PubMed Citation Articles by Childs, A. C. Articles by Leeuwenburgh, C.

Doxorubicin Treatment in Vivo Causes Cytochrome c Release and Cardiomyocyte Apoptosis, As Well As Increased Mitochondrial Efficiency, Superoxide Dismutase Activity, and Bcl-2:Bax Ratio¹

University of Florida, Biochemistry of Aging Laboratory, College of Health and Human Performance, Gainesville, Florida 32611

There have been very few investigations as to whether mitochondrial-mediated apoptosis in vivo is the underlying mechanism of doxorubicin cardiotoxicity. Moreover, no investigations have been conducted to determine whether there are adaptive responses after doxorubicin treatment. We administered a single dose of doxorubicin (20 mg/kg) to male rats and isolated intact mitochondria from their hearts 4 days later. Apoptosis, as determined by the amount of cytosolic mononucleosomal and oligonucleosomal DNA fragments (180 bp or multiples), was significantly increased after doxorubicin treatment. In contrast, Troponin-T, a cardiac-specific marker for necrotic damage, was unaltered 4 days after doxorubicin treatment. Cytosolic cytochrome c increased 2-fold in the doxorubicin-treated rats and was significantly correlated (r = 0.88; P < 0.01) with the increase in caspase-3 activity observed. Moreover, the level of bleomyocin-detectable iron in serum was significantly increased and may have contributed to the increase in oxidative stress, which was indicated by an increase in cytosolic 8-iso prostaglandin F₂. Cytosolic copper zinc superoxide dismutase activity also increased significantly further supporting the notion that doxorubicin increases superoxide radical production. In addition to adaptations to antioxidant defenses, other adaptive mechanisms occurred in the mitochondria such as an increase in the respiratory P/O ratio and an increase in the Bcl-2:Bax ratio. These findings demonstrate that doxorubicin induces oxidative stress and mitochondrial-mediated apoptosis, as well as adaptive responses by the mitochondria to protect cardiac myocytes in vivo.

This article has been cited by other articles:

				M. A. Frias, U. Lang, C. Gerber-Wicht, and R. W. James Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis Cardiovasc Res, September 18, 2009; (2009) cvp289v2. [Abstract] [Full Text] [PDF]

				P. Mukhopadhyay, M. Rajesh, S. Batkai, Y. Kashiwaya, G. Hasko, L. Liaudet, C. Szabo, and P. Pacher Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1466 - H1483. [Abstract] [Full Text] [PDF]

				H. J. Choi, M. R. Seon, S. S. Lim, J.-S. Kim, H. S. Chun, and J. H. Y. Park Hexane/Ethanol Extract of Glycyrrhiza uralensis Licorice Suppresses Doxorubicin-Induced Apoptosis in H9c2 Rat Cardiac Myoblasts Experimental Biology and Medicine, December 1, 2008; 233(12): 1554 - 1560. [Abstract] [Full Text] [PDF]

				M. A. Frias, S. Somers, C. Gerber-Wicht, L. H. Opie, S. Lecour, and U. Lang The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis Cardiovasc Res, October 1, 2008; 80(1): 69 - 77. [Abstract] [Full Text] [PDF]

				C. A. Goodyear-Bruch, J. Jegathesan, R. L. Clancy, and J. D. Pierce Apoptotic-Related Protein Expression in the Diaphragm and the Effect of Dopamine During Inspiratory Resistance Loading Biol Res Nurs, April 1, 2008; 9(4): 293 - 300. [Abstract] [PDF]

				V. Parra, V. Eisner, M. Chiong, A. Criollo, F. Moraga, A. Garcia, S. Hartel, E. Jaimovich, A. Zorzano, C. Hidalgo, et al. Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis Cardiovasc Res, January 15, 2008; 77(2): 387 - 397. [Abstract] [Full Text] [PDF]

				A. d. de Tassigny, A. Berdeaux, R. Souktani, P. Henry, and B. Ghaleh The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1/2 Eur J Heart Fail, January 1, 2008; 10(1): 39 - 46. [Abstract] [Full Text] [PDF]

				P. Mukhopadhyay, S. Batkai, M. Rajesh, N. Czifra, J. Harvey-White, G. Hasko, Z. Zsengeller, N. P. Gerard, L. Liaudet, G. Kunos, et al. Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity J. Am. Coll. Cardiol., August 7, 2007; 50(6): 528 - 536. [Abstract] [Full Text] [PDF]

				R. Nithipongvanitch, W. Ittarat, J. M. Velez, R. Zhao, D. K. St. Clair, and T. D. Oberley Evidence for p53 as Guardian of the Cardiomyocyte Mitochondrial Genome Following Acute Adriamycin Treatment J. Histochem. Cytochem., June 1, 2007; 55(6): 629 - 639. [Abstract] [Full Text] [PDF]

				A. Clerk, T. J. Kemp, G. Zoumpoulidou, and P. H. Sugden Cardiac myocyte gene expression profiling during H2O2-induced apoptosis Physiol Genomics, April 24, 2007; 29(2): 118 - 127. [Abstract] [Full Text] [PDF]

				K. Li, R. Y. T. Sung, W. Z. Huang, M. Yang, N. H. Pong, S. M. Lee, W. Y. Chan, H. Zhao, M. Y. To, T. F. Fok, et al. Thrombopoietin Protects Against In Vitro and In Vivo Cardiotoxicity Induced by Doxorubicin Circulation, May 9, 2006; 113(18): 2211 - 2220. [Abstract] [Full Text] [PDF]

				A. J. Chicco, D. S. Hydock, C. M. Schneider, and R. Hayward Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity J Appl Physiol, February 1, 2006; 100(2): 519 - 527. [Abstract] [Full Text] [PDF]

				A. Thorburn and A. E. Frankel Apoptosis and anthracycline cardiotoxicity. Mol. Cancer Ther., February 1, 2006; 5(2): 197 - 199. [Full Text] [PDF]

				F.-F. Liu, J. R. Stone, A. J. T. Schuldt, K. Okoshi, M. P. Okoshi, M. Nakayama, K. K. L. Ho, W. J. Manning, M. A. Marchionni, B. H. Lorell, et al. Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H660 - H666. [Abstract] [Full Text] [PDF]

				A. Ascensao, J. Magalhaes, J. M. C. Soares, R. Ferreira, M. J. Neuparth, F. Marques, P. J. Oliveira, and J. A. Duarte Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H722 - H731. [Abstract] [Full Text] [PDF]

				P. W. Fisher, F. Salloum, A. Das, H. Hyder, and R. C. Kukreja Phosphodiesterase-5 Inhibition With Sildenafil Attenuates Cardiomyocyte Apoptosis and Left Ventricular Dysfunction in a Chronic Model of Doxorubicin Cardiotoxicity Circulation, April 5, 2005; 111(13): 1601 - 1610. [Abstract] [Full Text] [PDF]

				N. Nozaki, T. Shishido, Y. Takeishi, and I. Kubota Modulation of Doxorubicin-Induced Cardiac Dysfunction in Toll-Like Receptor-2-Knockout Mice Circulation, November 2, 2004; 110(18): 2869 - 2874. [Abstract] [Full Text] [PDF]

				K. A. Ahmad, K. B. Iskandar, J. L. Hirpara, M.-V. Clement, and S. Pervaiz Hydrogen Peroxide-Mediated Cytosolic Acidification Is a Signal for Mitochondrial Translocation of Bax during Drug-Induced Apoptosis of Tumor Cells Cancer Res., November 1, 2004; 64(21): 7867 - 7878. [Abstract] [Full Text] [PDF]

				J. Dunnick, J. Johnson, J. Horton, and A. Nyska Bis(2-chloroethoxy)methane-Induced Mitochondrial and Myofibrillar Damage: Short-Term Time-Course Study Toxicol. Sci., September 1, 2004; 81(1): 243 - 252. [Abstract] [Full Text] [PDF]

				G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity Pharmacol. Rev., June 1, 2004; 56(2): 185 - 229. [Abstract] [Full Text] [PDF]

				J. K. Dunnick, W. Lieuallen, C. Moyer, D. Orzech, and A. Nyska Cardiac Damage in Rodents after Exposure to Bis(2-chloroethoxy)methane Toxicol Pathol, April 1, 2004; 32(3): 309 - 317. [Abstract] [PDF]

				S. FOGLI, P. NIERI, and M. C. BRESCHI The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage FASEB J, April 1, 2004; 18(6): 664 - 675. [Abstract] [Full Text] [PDF]

				X. Liu, C. C. Chua, J. Gao, Z. Chen, C. L. C. Landy, R. Hamdy, and B. H. L. Chua Pifithrin-{alpha} protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H933 - H939. [Abstract] [Full Text] [PDF]

				K. B. Wallace, E. Hausner, E. Herman, G. D. Holt, J. T. Macgregor, A. L. Metz, E. Murphy, I.Y. Rosenblum, F. D. Sistare, and M. J. York Serum Troponins as Biomarkers of Drug-Induced Cardiac Toxicity Toxicol Pathol, January 1, 2004; 32(1): 106 - 121. [PDF]

				G.-C. Hur, S. J. Cho, C.-H. Kim, M. K. Kim, S. I. Bae, S. Y. Nam, J.-W. Park, W. H. Kim, and B. L. Lee Manganese Superoxide Dismutase Expression Correlates with Chemosensitivity in Human Gastric Cancer Cell Lines Clin. Cancer Res., November 15, 2003; 9(15): 5768 - 5775. [Abstract] [Full Text] [PDF]

				D. Lebrecht, B. Setzer, U.-P. Ketelsen, J. Haberstroh, and U. A. Walker Time-Dependent and Tissue-Specific Accumulation of mtDNA and Respiratory Chain Defects in Chronic Doxorubicin Cardiomyopathy Circulation, November 11, 2003; 108(19): 2423 - 2429. [Abstract] [Full Text] [PDF]

				Y.-H. Ling, L. Liebes, Y. Zou, and R. Perez-Soler Reactive Oxygen Species Generation and Mitochondrial Dysfunction in the Apoptotic Response to Bortezomib, a Novel Proteasome Inhibitor, in Human H460 Non-small Cell Lung Cancer Cells J. Biol. Chem., September 5, 2003; 278(36): 33714 - 33723. [Abstract] [Full Text] [PDF]